Evidence map›Paper›PMID 37335321›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2023

A positive feedback cycle between the alarmin S100A8/A9 and NLRP3 inflammasome-GSDMD signalling reinforces the innate immune response in Candida albicans keratitis.

Xiaolong Fang, Huifang Lian, Shuang Liu, Jingcun Dong, Xia Hua, Wenguang Li, Chunyang Liao, Xiaoyong Yuan

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Microorganisms · 2025
    Article
  8. Neutrophil extracellular traps in homeostasis and disease.Signal transduction and targeted therapy · 2024
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Xiaolong FangSchool of Medicine, Nankai University, Tianjin, China.
Huifang LianTianjin Key Laboratory of Ophthalmology and Visual Science, Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin, China.
Shuang LiuState Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Centre for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China.
Jingcun DongState Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Centre for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China.
Xia HuaAier Eye Hospital, Tianjin, China.
Wenguang LiInstitute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
Chunyang LiaoState Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Centre for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China. cyliao@rcees.ac.cn.
Xiaoyong YuanSchool of Medicine, Nankai University, Tianjin, China. yuanxy_cn@hotmail.com.
Research Center for Eco-Environmental Sciences · CNTianjin Medical University · CNChinese Academy of Sciences · CNInstitute of Genetics and Developmental Biology · CNUniversity of Chinese Academy of Sciences · CN

Funding

K.C. Wong Education Foundation of China GJTD-2020-03National Key Research and Development Program of China 2019YFC1604803National Natural Science Foundation of China 21906179National Natural Science Foundation of China 81970772Science and Technology Program of Baoding of Huifang Lian 2141ZF086Tianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-016ATianjin Natural Science Foundation 21JCZDJC01250
6 · The paper itself

Abstract

objectiveFungal keratitis is a severe sight-threatening ocular infection, without effective treatment strategies available now. Calprotectin S100A8/A9 has recently attracted great attention as a critical alarmin modulating the innate immune response against microbial challenges. However, the unique role of S100A8/A9 in fungal keratitis is poorly understood.

methodsExperimental fungal keratitis was established in wild-type and gene knockout (TLR4

resultsHerein, we characterized the proteome of mouse corneas infected with Candida albicans and found that S100A8/A9 was robustly expressed at the early stage of the disease. S100A8/A9 significantly enhanced disease progression by promoting NLRP3 inflammasome activation and Caspase-1 maturation, accompanied by increased accumulation of macrophages in infected corneas. In response to Candida albicans infection, toll-like receptor 4 (TLR4) sensed extracellular S100A8/A9 and acted as a bridge between S100A8/A9 and NLRP3 inflammasome activation in mouse corneas. Furthermore, the deletion of TLR4 resulted in noticeable improvement in fungal keratitis. Remarkably, NLRP3/GSDMD-mediated macrophage pyroptosis in turn facilitates S100A8/A9 secretion during Candida albicans keratitis, thus forming a positive feedback cycle that amplifies the proinflammatory response in corneas.

conclusionsThe present study is the first to reveal the critical roles of the alarmin S100A8/A9 in the immunopathology of Candida albicans keratitis, highlighting a promising approach for therapeutic intervention in the future.

Indexed as

Candida albicansKeratitisAlarminsAnimalsCalgranulin AFeedbackImmunity, InnateInflammasomesMiceNLR Family, Pyrin Domain-Containing 3 ProteinToll-Like Receptor 4AlarminsCalgranulin AInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinToll-Like Receptor 4Alarmin S100A8/A9Candida albicans keratitisInnate immunityMacrophage pyroptosisNLRP3 inflammasome activationTLR4 pathway

Identifiers

PMID37335321
OpenAlexW4381192406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.